Share
TRUEinvivo is pleased to announce that it went live on the SyndicateRoom investment platform on 27th February 2019. This enables the company to be visible to the wide network of potential investors who are registered with SyndicateRoom. The company chose SyndicateRoom as its online investment partner because of its excellent reputation in the equity crowdfunding market, its high levels of vetting and due diligence, and the professional help it gives its clients to present themselves well. SyndicateRoom joins TRUEinvivo’s offline investment network partner Nexus Investment Ventures Ltd (NIVL) in connecting TRUEinvivo with High Net Worth or Sophisticated potential investors. Note that this is an information news post and is not an invitation to invest in the company.
Related Posts
Innovate UK showcases TRUEinvivo® founder for Women in Innovation award, spotlighting Dr. Shakardokht Jafari's success.
TrueInvivo’s® DOSEmapper™ showcased at BRSS, ensuring precise gamma knife dosimetry and improved radiation safety.
TRUEinvivo's DOSEmapper™ technology receives enthusiastic feedback from industry leaders at ESTRO37 conference.
TrueInvivo enhances cancer care with accurate, high-resolution in-vivo dosimetry system, optimizing radiotherapy outcomes.
